ERK2 signaling pathway regulates the progression liver fibrosis through multiple HCC-related biomarkers such as FoxM1, MMP9, CD133 etc. ERK2 deficiency could lead to reduction in cell proliferation in liver fibrosis. This evidence concerns the gene MAPK1 and hepatocellular carcinoma.